As a model system to systematically analyze the molecular consequences of CYFIP2 mutations normally occurring in neurodevelopmental disorders, we focused on B16-F1 mouse melanoma cells, in which the CYFIP1 and CYFIP2 genes were disrupted using CRISPR/Cas9 [7]. The gene discussed is CYFIP2; the disease is neurodevelopmental disorder.